Kraków, Poland

Piotr Kowalski


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Piotr Kowalski

Introduction

Piotr Kowalski is a notable inventor based in Kraków, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases. With two patents to his name, Kowalski's work is paving the way for advancements in medical treatments.

Latest Patents

Kowalski's latest patents focus on Arylosulfonamides for the treatment of CNS diseases. These patents detail Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds developed by Kowalski may be useful for the treatment and/or prevention of disorders of the central nervous system. His innovative approach in this area highlights the potential for new therapeutic options.

Career Highlights

Kowalski is currently employed at Adamed Sp. z o.o., a company known for its commitment to research and development in the pharmaceutical sector. His role at Adamed allows him to further explore his interests in CNS disorders and contribute to the company's mission of improving patient outcomes through innovative solutions.

Collaborations

Kowalski collaborates with talented coworkers, including Jolanta Jaśkowska and Monika Marcinkowska. Their combined expertise fosters a productive environment for research and development, enhancing the potential for groundbreaking discoveries in their field.

Conclusion

Piotr Kowalski's contributions to the field of pharmaceuticals, particularly through his patents on Arylosulfonamides, demonstrate his commitment to advancing medical science. His work at Adamed and collaborations with skilled colleagues position him as a key player in the ongoing fight against CNS diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…